NCT02391337View on ClinicalTrials.gov

Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF)

PHASE4CompletedINTERVENTIONAL
Enrollment

161

Participants

Timeline

Start Date

December 20, 2016

Primary Completion Date

April 15, 2019

Study Completion Date

September 16, 2019

Conditions
Permanent Atrial Fibrillation
Interventions
DRUG

Bisoprolol

Drug intervention

DRUG

Digoxin

Drug intervention

Trial Locations (2)

Unknown

City Hospital, Birmingham

Queen Elizabeth Hospital, Birmingham

All Listed Sponsors
lead

University of Birmingham

OTHER

NCT02391337 - Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) | Biotech Hunter | Biotech Hunter